solid lipid nanoparticles (slns) (NanoCarrier Co)
90
Structured Review
NanoCarrier Co
solid lipid nanoparticles (slns)
Solid Lipid Nanoparticles (Slns), supplied by NanoCarrier Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/solid+lipid+nanoparticles+(slns)/solid+lipid+nanoparticles/pm39914570-2-18-7
Average 90 stars, based on 1 article reviews
Solid Lipid Nanoparticles (Slns), supplied by NanoCarrier Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/solid+lipid+nanoparticles+(slns)/solid+lipid+nanoparticles/pm39914570-2-18-7
Average 90 stars, based on 1 article reviews
solid lipid nanoparticles (slns) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Hijacking the intrinsic vitamin B 12 pathway for the oral delivery of nanoparticles, resulting in enhanced in vivo anti-leishmanial activity. Article Snippet: Surface-functionalized vitamin B12 (VB12) biocompatible nanoparticles exploit the well-characterized uptake pathway of VB12, shielding it from enzymatic degradation and inadequate absorption.. In this perspective, subsequent to escalated mucus interaction and diffusion analysis, the nanoparticles were investigated by immunostaining with the anti-CD320 antibody, and their internalization mechanisms were examined by selectively blocking specific uptake processes.. It was observed that their internalization occurred via an energy-dependent clathrin-mediated mechanism, simultaneously highlighting their remarkable ability to bypass the P-glycoprotein efflux. Article Title: Comprehensive insights into herbal P-glycoprotein inhibitors and nanoformulations for improving anti-retroviral therapy efficacy Article Snippet: the worldwide Hiv cases were 39.0 million (33.1–45.7 million) in 2022.. Due to genetic variations, Hiv-1 is more easily transmitted than Hiv-2 and favours cD4 + t cells and macrophages, producing AiDS. conventional Hiv drug therapy has many drawbacks, including adherence issues leading to resistance, side effects that lower life quality, drug interactions, high costs limiting global access, inability to eliminate viral reservoirs, chronicity requiring lifelong treatment, emerging toxicities, and a focus on managing infections. conventional dosage forms have bioavailability issues due to intestinal P-glycoprotein (P-gp) efflux, which can reduce anti-retroviral drug efficacy and lead to resistance.. Use of phyto-constituents with P-gp regulating actions has great benefits for semi-synthetic modification to create formulations with greater bioavailability and reduced toxicity, which improves drug effectiveness. lipid-based nanocarriers, solid lipid nanoparticles, nanostructured lipid carriers, polymer-based nanocarriers, and inorganic nanoparticles may inhibit P-gp efflux. employing potent P-gp inhibitors within nanocarriers as a trojan horse approach can enhance the intracellular accumulation of anti-retroviral drugs (ARDs), which are substrates for efflux transporters. this technique increases oral bioavailability and offers lower-dose options, boosting Hiv patient compliance and lowering costs. Article Title: Harnessing phytoconstituents in ethosomes: A new frontier in skin disorder management. Article Snippet: The rising incidence of skin disorders has necessitated the exploration of innovative therapeutic modalities that harness the beneficial properties of natural compounds.. Phytoconstituents, renowned for their diverse pharmacological attributes, present considerable promise in the management of various dermatological conditions.. This review delineates the integration of phytoconstituents into ethosomal formulations, which are advanced lipid-based carriers specifically designed to enhance transdermal delivery. Concentration Assay:Article Title: Curcumin-Loaded Lipid Nanocarriers: A Targeted Approach for Combating Oxidative Stress in Skin Applications Article Snippet: Nanocarrier preparation was conducted using the hot emulsification method followed by sonication, as previously described [ ]. .. The lipid-phase concentration in all formulations was 3% w / w . The compositions of the lipid phase for each nanocarrier were as follows: SLNs (solid lipid nanoparticles): softisan Modification:Article Title: Lysozyme Interaction with Phospholipid Nanodroplets Probed by Sum Frequency Scattering Vibrational Spectroscopy. Article Snippet: When a nanoparticle (NP) is introduced into a biological environment, its identity and interactions are immediately attributed to the dense layer of proteins that quickly covers the particle.. The formation of this layer, dubbed the protein corona, is in general a combination of proteins interacting with the surface of the NP and a contest between other proteins for binding sites either at the surface of the NP or upon the dense layer.. Despite the importance for surface engineering and drug development, the molecular mechanisms and structure behind interfacial biomolecule action have largely remained elusive. Emulsion:Article Title: Lysozyme Interaction with Phospholipid Nanodroplets Probed by Sum Frequency Scattering Vibrational Spectroscopy. Article Snippet: When a nanoparticle (NP) is introduced into a biological environment, its identity and interactions are immediately attributed to the dense layer of proteins that quickly covers the particle.. The formation of this layer, dubbed the protein corona, is in general a combination of proteins interacting with the surface of the NP and a contest between other proteins for binding sites either at the surface of the NP or upon the dense layer.. Despite the importance for surface engineering and drug development, the molecular mechanisms and structure behind interfacial biomolecule action have largely remained elusive. |
